- Report
- October 2020
- 18 Pages
Italy
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
France
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
United Kingdom
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
China
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
South Korea
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 19 Pages
Russia
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
Brazil
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
Mexico
From €2845EUR$2,995USD£2,448GBP
- Report
- October 2020
- 18 Pages
Japan
From €2845EUR$2,995USD£2,448GBP
- Report
- May 2023
- 9 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- February 2023
- 11 Pages
Global
From €2993EUR$3,150USD£2,574GBP
- Report
- July 2021
- 11 Pages
Global
From €2850EUR$3,000USD£2,452GBP
- Report
- October 2019
- 99 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- March 2022
- 205 Pages
Global
From €3387EUR$3,565USD£2,913GBP
The Inferior Vena Cava Filter (IVCF) is a medical device used in the treatment of deep vein thrombosis (DVT). It is a small, umbrella-like device that is inserted into the inferior vena cava, the largest vein in the body, to prevent blood clots from traveling to the lungs and causing a pulmonary embolism. IVCFs are used when anticoagulant medications are not effective or when a patient is at high risk for a pulmonary embolism.
The IVCF market is a segment of the larger cardiovascular devices market. It is a growing market, driven by the increasing prevalence of deep vein thrombosis and the need for effective treatments. The market is expected to benefit from technological advancements in the design and materials used in IVCFs, as well as the increasing number of clinical trials and studies conducted on the efficacy of IVCFs.
Some of the major companies in the IVCF market include Boston Scientific, Cook Medical, C.R. Bard, and B. Braun. Show Less Read more